Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Asthma Drugs Market From 2025 to 2029?

In the past few years, the market size for asthma drugs has seen a consistent increase. The market is predicted to expand from $23.96 billion in 2024 to $24.93 billion in 2025, with a compound annual growth rate (CAGR) of 4.0%. The historic growth can be credited to elements such as environmental factors, a rise in respiratory ailments, alterations in lifestyle, and the advancement in healthcare infrastructure.

The market size for asthma medication is projected to see robust expansion in the next several years. The market is expected to reach $31.38 billion in 2029, with a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this projected growth include increasing levels of air pollution, an aging population, greater awareness of health care needs, the rise of personalized medicine, and advancements in biopharmaceuticals. Key trends expected throughout this period involve therapies based on small molecules, home-centered asthma treatment, therapies informed by biomarkers, progress in the treatment of severe asthma, and cooperative efforts in asthma research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

What Elements Are Contributing To Growth In The Asthma Drugs Market?

The escalating occurrence of asthma-related conditions is projected to drive the expansion of the asthma medication market in the future. Asthma is a chronic disease that leads to inflammation and swelling in airflow tracts, resulting in the airways carrying air from the nose and mouth to the lungs being narrowed. Due to the rise in asthma instances, the development and identification of new drugs to treat asthma disorders have notably increased. For example, in April 2024, Asthma + Lung UK, a charity based in England that assists individuals with lung conditions, reported that there were 1,146 asthma-related fatalities in England in 2021. This number increased to 1,236 in 2022, indicating an alarming rise in deaths linked to this condition throughout the year.

Which Segments Are Detailed In The Global Asthma Drugs Market Report?

The asthma drugs market covered in this report is segmented –

1) By Type Of Asthma: Allergic, Non-Allergic

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

3) By Therapy: Preventive, Curative

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

5) By End-User: Asthma Patients, COPD Patients

Subsegments:

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

Which Emerging Trends And Strategic Shifts Are Shaping The Asthma Drugs Market?

The focus of major firms in the asthma drugs market is on developing innovations, particularly Fixed-Dose Combination (FDC) drugs, to increase the effectiveness of treatment and ensure better patient compliance. Distributed as a tablet, capsule, or inhaler, a fixed-dose combination (FDC) drug comprises two or more active substances delivered in a single dose. For example, Glenmark Pharmaceuticals, a pharmaceutical company from India, proclaimed in June 2022 the launch of Indamet, a fixed-dose combination (FDC) drug, designed for individuals in India suffering from uncontrolled asthma. This innovative solution fuses Indacaterol, a long-lasting beta-agonist, with Mometasone Furoate, an inhalable corticosteroid. It is available in different potencies, such as Indacaterol 150 mcg combined with Mometasone at 80 mcg, 160 mcg, and 320 mcg. Indamet, intended for daily use, is targeted at adults and adolescents who are 12 years and older.

Who Are The Key Contributors To Growth In The Asthma Drugs Market?

Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Which Region Is Projected To Lead The Asthma Drugs Market By 2025?

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model